{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:07:31Z","timestamp":1789243651761,"version":"build-2803163510"},"reference-count":8,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,8]],"date-time":"2027-09-08T00:00:00Z","timestamp":1820361600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["R01 CA243445"],"award-info":[{"award-number":["R01 CA243445"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["R01 CA212600"],"award-info":[{"award-number":["R01 CA212600"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["U01 CA224012"],"award-info":[{"award-number":["U01 CA224012"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["R21 CA263996"],"award-info":[{"award-number":["R21 CA263996"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.trecan.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:34:11Z","timestamp":1786019651000},"page":"793-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HuR degradation reveals dependencies in BRAF-driven cancers"],"prefix":"10.1016","volume":"12","author":[{"given":"Ivan R.","family":"Siordia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-4365","authenticated-orcid":false,"given":"Dan A.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.07.005_bb0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wrna.4","article-title":"Posttranscriptional regulation of cancer traits by HuR","volume":"1","author":"Abdelmohsen","year":"2010","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"key":"10.1016\/j.trecan.2026.07.005_bb0010","article-title":"Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)","volume":"11","author":"Schultz","year":"2020","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"key":"10.1016\/j.trecan.2026.07.005_bb0015","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1158\/0008-5472.CAN-23-0972","article-title":"Targeting the RNA-binding protein HuR in cancer","volume":"83","author":"Finan","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.07.005_bb0020","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1038\/s41467-023-42546-2","article-title":"A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation","volume":"14","author":"Fletcher","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.07.005_bb0025","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1021\/jacsau.5c00551","article-title":"Druglike molecular degraders of the oncogenic RNA-binding protein HuR","volume":"5","author":"Kassabri","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.trecan.2026.07.005_bb0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41586-026-10613-5","article-title":"Molecular glue degraders of HuR suppress BRAF-mutant colorectal cancer","volume":"655","author":"Lu","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.07.005_bb0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","article-title":"Alternative splicing and related RNA binding proteins in human health and disease","volume":"9","author":"Tao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.005_bb0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/2159-8290.CD-11-0341","article-title":"EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib","volume":"2","author":"Corcoran","year":"2012","journal-title":"Cancer Discov."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:49:13Z","timestamp":1789242553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2405803326001615"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.07.005","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HuR degradation reveals dependencies in BRAF-driven cancers","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}